Yanping Yin

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

T. Aittokallio, S. Fernandes, K. Taskén, 2022, bioRxiv.

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine

G. Tjønnfjord, A. Tveita, L. Munthe, 2023, Cell death discovery.